The European HealthTech M&A and funding environment is characterised by a "flight to quality," increased investor selectivity, and a strong focus on proven business models and clear pathways to profitability. The market is maturing, favouring larger, strategic deals and companies with demonstrable clinical and financial success. Here are 10 key factors European HealthTech founders should be aware of: